drugset / Trial / NCT04263363
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
Phase 4
Completed
12248 enrolled
University of California, Los Angeles
Merck Sharp & Dohme LLC · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to: 1. Perform a retrospective analysis on data contained in the UCLA Perioperative Data Warehouse on the incidence of respiratory dysfunction in the post-operative care unit (PACU) before and after the introduction of sugammadex into clinical practice. 2. Develop and implement a clinical best practice pathway designed to prevent postoperative respiratory complications in higher risk patients (such as those with OSA or preexisting respiratory disease) using education and clinical decision support in patients.
Timeline
- Start
- 2022-02-18
- Primary completion
- 2024-05-07
- Completion
- 2025-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sugammadex | Other / unclassified | 100 mg/ml | — |